BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Liu L, Zhan S, Chen L, Wang Y, Zhang Y, Du J, Wu Y, Gu L. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells. Int J Mol Sci 2018;19:E3739. [PMID: 30477221 DOI: 10.3390/ijms19123739] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun Z, Cao Y, Xing Y, Wu M, Shao X, Huang Q, Bai L, Wang L, Zhao Y, Wu Y. Antiangiogenic effect of arsenic trioxide in HUVECs by FoxO3a-regulated autophagy. J Biochem Mol Toxicol 2021;35:e22728. [PMID: 33592126 DOI: 10.1002/jbt.22728] [Reference Citation Analysis]
2 Du W, Ren L, Hamblin MH, Fan Y. Endothelial Cell Glucose Metabolism and Angiogenesis. Biomedicines 2021;9:147. [PMID: 33546224 DOI: 10.3390/biomedicines9020147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhong X, Di Z, Xu Y, Liang Q, Feng K, Zhang Y, Di L, Wang R. Mineral medicine: from traditional drugs to multifunctional delivery systems. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00577-9] [Reference Citation Analysis]
4 Hsin IL, Chou YH, Hung WL, Ko JL, Wang PH. The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death. Cancers (Basel) 2019;12:E108. [PMID: 31906234 DOI: 10.3390/cancers12010108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen YH, Li CL, Chen WJ, Liu J, Wu HT. Diverse roles of FOXO family members in gastric cancer. World J Gastrointest Oncol 2021; 13(10): 1367-1382 [PMID: 34721771 DOI: 10.4251/wjgo.v13.i10.1367] [Reference Citation Analysis]
6 Li S, Ren Q. Effects of Arsenic on wnt/β-catenin Signaling Pathway: A Systematic Review and Meta-analysis. Chem Res Toxicol 2020;33:1458-67. [PMID: 32307979 DOI: 10.1021/acs.chemrestox.0c00019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yu M, Zhang Y, Fang M, Jehan S, Zhou W. Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy. Pharmaceutics 2022;14:743. [DOI: 10.3390/pharmaceutics14040743] [Reference Citation Analysis]
8 Gurnari C, Falconi G, De Bellis E, Voso MT, Fabiani E. The Role of Forkhead Box Proteins in Acute Myeloid Leukemia. Cancers (Basel) 2019;11:E865. [PMID: 31234353 DOI: 10.3390/cancers11060865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ma W, Shen H, Li Q, Song H, Guo Y, Li F, Zhou X, Guo X, Shi J, Cui Q, Xing J, Deng J, Yu Y, Liu W, Zhao H. MARVELD1 attenuates arsenic trioxide-induced apoptosis in liver cancer cells by inhibiting reactive oxygen species production. Ann Transl Med 2019;7:200. [PMID: 31205918 DOI: 10.21037/atm.2019.04.38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Farhan M, Silva M, Xingan X, Huang Y, Zheng W. Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis. Cells 2020;9:E1586. [PMID: 32629884 DOI: 10.3390/cells9071586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Joannes A, Morzadec C, Duclos M, Gutierrez FL, Chiforeanu DC, Le Naoures C, De Latour B, Rouzé S, Wollin L, Jouneau S, Vernhet L. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Toxicol Appl Pharmacol 2022;:115972. [PMID: 35276128 DOI: 10.1016/j.taap.2022.115972] [Reference Citation Analysis]
12 Zhang J, Zhang Y, Wang W, Zhang Z. Potential molecular mechanisms underlying the effect of arsenic on angiogenesis. Arch Pharm Res 2019;42:962-76. [PMID: 31701373 DOI: 10.1007/s12272-019-01190-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 2020;39:1179-203. [PMID: 32894370 DOI: 10.1007/s10555-020-09925-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
14 Xie H, Ma Y, Li J, Chen H, Xie Y, Chen M, Zhao X, Tang S, Zhao S, Zhang Y, Du J, Zhang F, Gu L. WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling. Front Pharmacol 2020;11:98. [PMID: 32174831 DOI: 10.3389/fphar.2020.00098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]